Lista de obras -

Adherence to immunotherapy in times of financial crisis

artículo científico publicado en 2013

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

artículo científico publicado en 2011

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

artículo científico publicado en 2014

Bone Marrow Expression of Mast Cell Disorders

artículo científico publicado en 2018

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

artículo científico

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

artículo científico publicado en 2013

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

artículo científico publicado en 2018

Childhood mastocytosis

artículo científico publicado en 2012

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

artículo científico publicado en 2011

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

artículo científico publicado en 2010

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

artículo científico publicado en 2015

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

artículo científico publicado en 2016

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

scientific article published on 01 September 2012

Current state of biology and diagnosis of clonal mast cell diseases in adults.

artículo científico publicado en 2012

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

artículo científico publicado en 2019

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

scientific article published on 17 May 2018

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

artículo científico

Dermoscopic features of skin lesions in patients with mastocytosis

artículo científico publicado en 2011

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

artículo científico publicado en 2015

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

artículo científico publicado en 2015

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

artículo científico publicado el 10 de noviembre de 2010

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

artículo científico publicado en 2011

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

artículo científico publicado en 2015

Extensive blistering is a predictor for severe complications in children with mastocytosis

artículo científico publicado en 2012

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

artículo científico

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

artículo científico publicado en 2019

Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host

artículo científico publicado en 2012

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

artículo científico publicado en 2009

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

artículo científico publicado en 2012

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

artículo científico publicado en 2015

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

artículo científico publicado el 1 de abril de 2011

Insights in Anaphylaxis and Clonal Mast Cell Disorders.

artículo científico publicado en 2017

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

artículo científico publicado en 2015

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

artículo científico publicado en 2015

Mast Cells as Key Players in Allergy and Inflammation

artículo científico publicado en 2018

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

artículo científico publicado en 2011

Mast cell-related disorders presenting with Kounis syndrome

artículo científico publicado en 2012

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

artículo científico publicado en 2010

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

artículo científico publicado en 2022

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

artículo científico publicado en 2013

Perioperative anaphylaxis in a patient with a solitary mastocytoma

artículo científico publicado en 2019

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)

artículo científico publicado en 2007

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

artículo científico publicado en 2009

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

scientific article published on 05 February 2019

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

artículo científico publicado en 2014

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

artículo científico publicado en 2015

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

artículo científico publicado en 2008

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

artículo científico publicado en 2013

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

artículo científico publicado en 2013

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

artículo científico publicado en 2012

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

artículo científico publicado en 2015

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

artículo científico publicado en 2016

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

artículo científico publicado en 2014

Tryptase increase on the first day of hymenoptera venom immunotherapy might be a predictor of future systemic reactions during treatment.

artículo científico publicado en 2018

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.

artículo científico publicado en 2013

Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.

artículo científico publicado en 2011

Lista de obras de

Adherence to immunotherapy in times of financial crisis

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Bone Marrow Expression of Mast Cell Disorders

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

Childhood mastocytosis

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

Current state of biology and diagnosis of clonal mast cell diseases in adults.

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

Dermoscopic features of skin lesions in patients with mastocytosis

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow

Extensive blistering is a predictor for severe complications in children with mastocytosis

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

Fulminant necrotizing fasciitis caused by Serratia marcescens in an immunosuppressed host

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosis ⬇️

Insights in Anaphylaxis and Clonal Mast Cell Disorders.

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

Mast Cells as Key Players in Allergy and Inflammation

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

Mast cell-related disorders presenting with Kounis syndrome

Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes.

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Perioperative anaphylaxis in a patient with a solitary mastocytoma

Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)

Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis.

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Tryptase increase on the first day of hymenoptera venom immunotherapy might be a predictor of future systemic reactions during treatment.

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.

Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.